We are live on ! Find out more
MA

Marshwinds Advisory Portfolio holdings

AUM $187M
1-Year Est. Return 1.79%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
-1.79%
3 Year Est. Return
+32.92%
5 Year Est. Return
+52.83%
10 Year Est. Return
AUM
$192M
AUM Growth
+$5.22M
Cap. Flow
-$8.12M
Cap. Flow %
-4.24%
Top 10 Hldgs %
26.18%
Holding
143
New
1
Increased
11
Reduced
83
Closed
9

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$213K
2
XOM icon
ExxonMobil
XOM
+$12.5K
3
JPM icon
JPMorgan Chase
JPM
+$651
4
WFC icon
Wells Fargo
WFC
+$597
5
ABT icon
Abbott
ABT
+$132

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$936K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$628K
3
MSFT icon
Microsoft
MSFT
+$457K
4
AMGN icon
Amgen
AMGN
+$377K
5
MMM icon
3M
MMM
+$315K

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Consumer Staples 17%
3 Industrials 16.81%
4 Technology 15.55%
5 Communication Services 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
1
Coca-Cola
KO
$377B
$7.23M 3.78%
168,365
-2,372
-1% -$101K
GE icon
2
GE Aerospace
GE
$375B
$5.86M 3.06%
39,269
-832
-2% -$118K
MDLZ icon
3
Mondelez International
MDLZ
$79.6B
$5.43M 2.84%
121,191
-2,401
-2% -$107K
T
4
DELISTED
A T & T CORP (NEW)
T
$5.36M 2.8%
155,847
-4,662
-3% -$160K
MSFT icon
5
Microsoft
MSFT
$3.44T
$4.79M 2.5%
86,392
-8,688
-9% -$457K
AMGN icon
6
Amgen
AMGN
$208B
$4.69M 2.45%
28,904
-2,400
-8% -$377K
ORCL icon
7
Oracle
ORCL
$371B
$4.46M 2.33%
122,200
-450
-0.4% -$17.2K
DD
8
DELISTED
Du Pont De Nemours E I
DD
$4.24M 2.21%
63,581
-298
-0.5% -$18.9K
PFE icon
9
Pfizer
PFE
$143B
$4.23M 2.21%
138,143
-6,553
-5% -$206K
PG icon
10
Procter & Gamble
PG
$335B
$3.86M 2.01%
48,570
-1,009
-2% -$77.1K
INTC icon
11
Intel
INTC
$468B
$3.65M 1.91%
105,948
-2,798
-3% -$94.6K
MRK icon
12
Merck
MRK
$322B
$3.63M 1.89%
71,997
-3,140
-4% -$158K
LLY icon
13
Eli Lilly
LLY
$1.02T
$3.62M 1.89%
43,002
+1
+0% +$83
XOM icon
14
ExxonMobil
XOM
$641B
$3.52M 1.84%
45,135
+156
+0.3% +$12.5K
IBM icon
15
IBM
IBM
$209B
$3.51M 1.83%
26,678
-1,695
-6% -$228K
CSCO icon
16
Cisco
CSCO
$457B
$3.31M 1.73%
122,025
-4,050
-3% -$112K
MMM icon
17
3M
MMM
$90.8B
$3.16M 1.65%
25,121
-2,450
-9% -$315K
KHC icon
18
Kraft Heinz
KHC
$30.8B
$3.14M 1.64%
43,206
-922
-2% -$68K
EMR icon
19
Emerson Electric
EMR
$84.2B
$3.14M 1.64%
65,634
-444
-0.7% -$21.1K
BMY icon
20
Bristol-Myers Squibb
BMY
$133B
$3.05M 1.59%
44,367
-1,050
-2% -$69.4K
SO icon
21
Southern Company
SO
$109B
$3.01M 1.57%
64,293
-297
-0.5% -$13.5K
NOC icon
22
Northrop Grumman
NOC
$77.1B
$2.97M 1.55%
15,728
RTN
23
DELISTED
Raytheon Company
RTN
$2.79M 1.46%
22,417
+1
+0% +$120
HD icon
24
Home Depot
HD
$331B
$2.78M 1.45%
21,040
-172
-0.8% -$21.9K
INTU icon
25
Intuit
INTU
$86.5B
$2.7M 1.41%
27,979
+1
+0% +$97

Similar funds

Marshwinds Advisory's Q4 2015 Portfolio in Review

As of Q4 2015, Marshwinds Advisory held 143 positions worth $192M, up 2.8% from $186M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshwinds Advisory withdrew a net $8.12M in Q4 2015, closing 9 positions and reducing 83 holdings. Its most notable exit was Apple, an estimated $936K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Marshwinds Advisory opened a new position in Thermo Fisher Scientific worth $227K.

  • Marshwinds Advisory's largest Q4 2015 buy was Thermo Fisher Scientific: 1,600 shares worth $227K.
  • Marshwinds Advisory added most to ExxonMobil in Q4 2015, an estimated $12.5K increase.
  • Marshwinds Advisory's biggest Q4 2015 reduction was Microsoft, cutting an estimated $457K.
  • Marshwinds Advisory fully exited Apple in Q4 2015, selling an estimated $936K.
  • Marshwinds Advisory's ten largest holdings make up 26% of its $192M portfolio in Q4 2015.
  • Marshwinds Advisory opened 1 new position and closed 9 in Q4 2015.
  • Marshwinds Advisory's portfolio value rose 2.8% quarter-over-quarter to $192M.

Based on Marshwinds Advisory's 13F filing for Q4 2015, filed 8 Jan 2016.